Table 5.
No | Name | Characteristics | Tested AKI model | Mechanism |
---|---|---|---|---|
1 | IL-10 | cytokine synthesis inhibitory factor | Ischemic- and cisplatin- AKI in the mouse |
reduce levels of TNF-α, ICAM-1, and iNOS |
2 | CXCR4 antagonist |
Plerixafor, a small-molecule antagonist of CXCR4 |
IRI in rats | reduce chemokines CXCL1, CXCL5 and IL-6 |
3 | TNF-α inhibition |
Inhibitors of TNF-α production (GM6001, pentoxifylline), anti-TNF-α antibody, specific TNF-α knockout |
cisplatin- AKI in Swiss-Webster mice |
decrease levels of TNF-α, TGF-β, RANTES, MIP-2, MCP-1, and IL-1β |
4 | ICAM-1 inhibition |
Specific ICAM-1 knockout, Anti-1CAm-1 antibody |
IRI in mice IRI in rats |
attenuate neutrophil endothelial interactions |
5 | CT-1 | A member of IL-6 family and a potent pleiotropic cytokine |
contrast-induced AKI in rats |
prevent tubular desepithelization and obstruction |
6 | NGAL | A member of the lipocalin super family with diverse function |
IRI in rats | inhibit activation of caspase-3 and expression of Bax |
7 | L-FABP | A member of intracellular lipid-binding proteins involved in the transportation of fatty acids |
AA-induced AKI in mice |
suppress the production of HEL, HO-1, and receptor for AGEs |
8 | sTM | A glycoprotein present on the membrane surface of endothelial cells in many organs, including lung, liver, and kidney. |
IRI in rats | improve microvascular erythrocyte flow rates |
9 | COMP-Ang1 | A soluble and potent Ang1 variant, act as the ligand for Tie2 tyrosine kinase receptor that is expressed on EC. |
unilateral ureteral obstruction-induce d renal fibrosis |
improve peritubular capillary and enhance renal tissue (re)perfusion |
10 | IGF | A hormone similar in molecular structure to insulin |
IRI in rats cisplatin- RPTC cisplatin- or HgCl2- AKI in mice |
ameliorate acute tubular necrosis; produce pro-survival factor IGF-1 |
11 | MFG-E8 | A protein involved in marking apoptotic cells for phagocytosis |
IRI in C57BL/6 mice |
suppress renal inflammation |
12 | EGF | A potent growth promoter to renal tubule cells, produced in large amounts in the kidney |
HgCl2- AKI in mice |
attenuate tubular necrosis |
13 | EGFR inhibitor |
erlotinib, a selective tyrosine kinase inhibitor that can block EGFR activity |
cisplatin- AKI in rats |
decrease apoptosis and proliferation of tubular cells |
14 | HGF | A potent mitogen for parenchymal liver, epithelial and endothelial cells, as a ligand of MET oncoprotein |
glycerol-, gentamicin- AKI in rats |
attenuate tubulointerstitial injury, leukocyte infiltration and Th1 polarization |
15 | EPO | Glycoprotein produced by the kidney that regulats red blood cell production in the bone marrow |
IR-, cisplatin- and contrast- AKI in mice or rats or pigs |
inhibit apoptosis and promote cellular regeneration |
16 | G-CSF | Glycoprotein that stimulates bone marrow to produce granulocytes and stem cells |
glycerol- AKI In C57BL/6 mice |
induction of HO-1 |
17 | NF-κB Blockade |
NF-κB decoy oligodeoxynucleotides; NF-κB inhibitor milrinone, resveratrol |
IRI in rats or mice | decrease MCP-1 expression and monocyte infiltration |
18 | HIF-1 | Ubiquitously expressed hypoxia-inducible transcription factor |
IR- or cisplatin- in rats |
ameliorate tubulointerstitial and vascular damage |
19 | HIF-2 | Hypoxia-inducible transcription factor mainly expressed on endothelial cells |
IRI in mice | protect from vascular damage and fibrosis |
20 | PKCδ knockdown |
A member of PKC subfamily involved in cell apoptosis |
cisplatin- AKI in mice, cisplatin-RPTCs |
Activated MAPKs for apoptosis and tissue damage |
21 | OMA1 knockdown |
a zinc metalloprotease located at mitochondrial inner membrane that is involved in mitochondrial inner membrane disruption in cell stress |
ATP-depleted RPTC, IRI in C57BL/6 mice |
mediate OPA1 proteolysis and mitochondrial fragmentation |
22 | Dicer deletion |
A key ribonuclease for microRNA production, Dicer deletion leads to a global downregulation of microRNAs |
IRI in mice | depletion of the majority of microRNAs |
23 | miR-687, -24 blockade |
endogenous, noncoding, small RNAs that regulate expression and function of genes |
hypoxia-induced RPTC injury / apoptosis, IRI in mice |
attenuate cell cycle activation and apoptosis |
24 | miR-127, -34a, -155, -126 blockade |
ameliorate histologic tubular damage, apoptosis |